Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Trimmed by McBroom & Associates LLC

McBroom & Associates LLC cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% during the 1st quarter, Holdings Channel reports. The firm owned 18,300 shares of the medical equipment provider’s stock after selling 205 shares during the quarter. Intuitive Surgical makes up approximately 5.2% of McBroom & Associates LLC’s holdings, making the stock its 4th largest holding. McBroom & Associates LLC’s holdings in Intuitive Surgical were worth $9,063,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. Brighton Jones LLC raised its position in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Union Bancaire Privee UBP SA bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $6,509,000. Bank of Stockton raised its position in shares of Intuitive Surgical by 13.5% in the fourth quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock valued at $606,000 after purchasing an additional 138 shares during the period. Vontobel Holding Ltd. raised its position in shares of Intuitive Surgical by 5.8% in the fourth quarter. Vontobel Holding Ltd. now owns 48,776 shares of the medical equipment provider’s stock valued at $25,459,000 after purchasing an additional 2,655 shares during the period. Finally, First Merchants Corp bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $201,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president now owns 907 shares of the company’s stock, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last 90 days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $512.18 on Friday. The firm has a fifty day moving average price of $526.57 and a 200 day moving average price of $538.46. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00. The firm has a market cap of $183.57 billion, a price-to-earnings ratio of 79.90, a P/E/G ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the business earned $1.50 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Piper Sandler decreased their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. Evercore ISI decreased their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a report on Wednesday, April 23rd. Finally, Citigroup reaffirmed a “buy” rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.